Plain-English translation of NCT06035250 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are developing an artificial intelligence tool that can predict how well chemotherapy will work for people with advanced gastric cancer. The tool learns from CT scans, biopsy images, and medical information to forecast treatment outcomes and help doctors make personalized treatment decisions. This study will test the tool using data from nearly 2,000 patients to make sure it works reliably.
Right now, doctors cannot reliably predict before treatment which patients will respond well to chemotherapy for gastric cancer. This tool aims to fill that gap by analyzing your imaging and biopsy data to forecast your individual response, so doctors can plan the best treatment strategy for you.
You likely qualify if…
You likely don't qualify if…
If you qualify, the research team will collect your CT scans, biopsy images, and clinical information that were already taken as part of your standard cancer care—you won't need extra scans or biopsies. Researchers will use this existing medical data to train and test the artificial intelligence tool. There are no additional visits or procedures required; you are simply allowing your medical information to help improve cancer treatment prediction for future patients.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
China